EBE Annual Meeting 2016: IMI – Opportunities and Challenges for developing Advanced Therapies

13 Jun 2016

Watch here the recording of the live broadcast

IMI – opportunities and challenges for developing Advanced Therapies (17h00 – 19h00 CET)
A keynote speech by Pierre Meulien, Executive Director IMI, followed by a moderated panel discussion on the opportunities for EBE members.



pierre-meulien300x300 Eduardo_Bravo_sq Holger-Schmoll 100x100 Salah-DIne Chibout Roberto_Gradnik-sq
Pierre Meulien
Executive Director
Eduardo Bravo
CEO TiGenix and incoming EBE President
Holger Schmoll
Salah-Dine Chibout
Global Head Discovery & Investigative Safety and Therapeutic Areas, Novartis Pharma
Roberto Gradnik
CEO Ixaltis and the outgoing EBE president
2017-09-05T12:48:52+00:00June 13, 2016|